drugset / Trial / NCT00018850

5HT3 Antagonism and Auditory Gating in Schizophrenia

NCT00018850

RandomizedCrossoverDouble-blindTreatment

Summary

The target groups in this study are brain waves and neurotransmitters (chemical messengers) in the brain. Subjects with diagnosed with schizophrenia will be studied. The study will help understand more about normal brain functioning and how that functioning differs in people with schizophrenia. Another purpose of this study is to determine how the altered brain functioning in schizophrenia contributes the symptoms found in the illness.

Timeline

Start
1998-06
Primary completion
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Haloperidol Other / unclassified
Subject Nicotine Unknown
Subject Ondansetron Other / unclassified

Indications